Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of COVID-19 infection. Abbott will sell this test for $5. It is highly portable (about the size of a credit card), affordable and provides results in 15 minutes.
Abbott’s fast, $5, 15-minute, easy-to-use COVID-19 antigen test receives FDA Emergency Use Authorization
August 28, 2020
Related blog posts
Search for COVID-19 drugs boosted by SARS discovery
August 27, 2020